No supraventricular arrhythmia on electrocardiogram (EKG)
Grade ? ventricular arrhythmia ? months prior to Day 
Having clinically significant cardiac disease such as ventricular arrhythmia requiring therapy, uncontrolled hypertension or any history of symptomatic CHF
Symptomatic arrhythmia or any uncontrolled arrhythmia requiring ongoing treatment.
Hiistory of ventricular arrhythmia
Serious arrhythmia,
History or presence of sustained bradycardia (? BPM), left bundle branch block, cardiac pacemaker or ventricular arrhythmia. Note: Patients with a supraventricular arrhythmia requiring medical treatment, but with a normal ventricular rate are eligible;
Absence of uncontrolled cardiac arrhythmia
known uncontrolled arrhythmias (except sinus arrhythmia) in the past  weeks.
Subjects with clinically apparent arrhythmia or arrhythmias who are not stable on medical management within two weeks of enrollment
Subjects with clinically apparent arrhythmia or arrhythmias who are not stable on medical management within two weeks of enrollment
History of clinically significant (as determined by the treating physician) atrial arrhythmia or any history of ventricular arrhythmia
History of heart failure or cardiac arrhythmia
Patients with history of atrial arrhythmia (requiring any anti-arrhythmic therapy) or patients with any history of ventricular arrhythmia are excluded
Patients requiring anti-arrhythmia cardiac medications are NOT eligible
History of arrhythmia requiring pharmacological or electrical treatment
Any history of ventricular arrhythmia; or
Symptomatic arrhythmia
Have any condition that increases the risk of abnormal ECG or cardiac arrhythmia
Current unstable arrhythmia requiring treatment.
Uncontrolled cardiac arrhythmia
Cardiac arrhythmia requiring maintenance medication
Patients must not have serious and inadequately controlled cardiac arrhythmia
Serious cardiac arrhythmia requiring medication
Cardiac arrhythmia not controlled with medical management
Serious uncontrolled cardiac arrhythmia grade II or higher according to NYHA
Significant cardiac arrhythmia
History or current evidence of cardiac arrhythmia and/or conduction abnormality
Serious and inadequately controlled cardiac arrhythmia
Known newly diagnosed cardiac arrhythmia; patients with an arrhythmia that has been stable for at least  months will be allowed to participate
Cardiac arrhythmia
Cardiac arrhythmia requiring medical management and/or pacemaker
Any history of ventricular arrhythmia
Treatment with anti arrhythmia therapy for ventricular arrhythmia <  weeks prior to enrollment
Symptomatic and/or serious uncontrolled arrhythmia
serious cardiac arrhythmia.
Uncontrolled cardiac arrhythmia
Serious uncontrolled cardiac arrhythmia.
Newly diagnosed cardiac arrhythmia; patients with an arrhythmia that has been stable for at least  months will be allowed to participate
Current, serious, clinically significant cardiac arrhythmias, defined as the existence of an absolute arrhythmia or ventricular arrythmias classified as Lown III, IV or V.
Recent malignant cardiac arrhythmias  all except sinus arrhythmia within  weeks prior to screening
Need for antiarrhythmic medical therapy for a ventricular arrhythmia
Known, uncontrolled cardiac arrhythmias (except sinus arrhythmia) within the past  weeks
Serious and inadequately controlled cardiac arrhythmia
History of heart failure or serious cardiac arrhythmia
Hx of ventricular arrhythmia or symptomatic conduction abnormality within m
Hx ventricular arrhythmia or symptomatic conduction abnormality within m
Uncontrolled arrhythmia or symptomatic cardiac or pulmonary disease
Newly diagnosed cardiac arrhythmia; patients with an arrhythmia that has been stable for at least  months will be allowed to participate
History of cardiac arrhythmia, controlled or uncontrolled, including ventricular and supraventricular arrhythmia
Subject has any form of known cardiac arrhythmia
Patient must not have serious and inadequately controlled cardiac arrhythmia
History of cardiac arrhythmia requiring treatment
New (<  months) cardiac arrhythmia (electrocardiogram [EKG] should be performed within  weeks of starting IFN gamma)
Symptomatic arrhythmia or any uncontrolled arrhythmia requiring ongoing treatment.
Arrhythmia requiring treatment which is not stabilized by the treatment